-
Active Stocks to Watch: Cellectar Biosciences (NASDAQ:CLRB), Onconova Therapeutics (NASDAQ:ONTX), Eagle Pharmaceuticals (NASDAQ:EGRX), Carrizo Oil & Gas (NASDAQ:CRZO), Reading International (NASDAQ:RDI)
On Friday shares of Cellectar Biosciences, Inc. (NASDAQ:CLRB) closed at $2.74. Cellectar Biosciences, Inc. (NASDAQ:CLRB), said late Monday it is postponing the release of first quarter financial results to take more time to evaluate the impact of a change in the way the company is accounting for previously-issued warrants. Onconova Therapeutics, Inc. (NASDAQ:ONTX) in last…
-
Best Stocks: Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Wal-Mart Stores Inc. (NYSE:WMT), Dunkin’ Brands Group (NASDAQ:DNKN), eBay Inc. (NASDAQ:EBAY), Outerwall Inc. (NASDAQ:OUTR)
On Monday shares of Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) closed at $55.42. On April 7, Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced that the United States Patent and Trademark Office (“USPTO”) has granted Patent No. 9,000,021 for the use of bendamustine for treating patients requiring restricted fluid and/or sodium intake. The patent issued expires in March 2033. On…
-
Moving Stocks: Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Merck & Co. Inc. (NYSE:MRK), Turkcell Iletisim Hizmetleri (NYSE:TKC), United Financial Bancorp (NASDAQ:UBNK), Symetra Financial (NYSE:SYA)
On Tuesday shares of Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) closed at $40.94. Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) on 17 March 2015, announced the pricing of an underwritten public offering of 1,320,276 shares of its common stock at a price to the public of $42.00 per share. 1,190,476 shares are being sold by Eagle and 129,800 shares are…
-
Top News: Talisman Energy Inc. (NYSE:TLM), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Alcoa Inc. (NYSE:AA), Eli Lilly and Company (NYSE:LLY), Pembina Pipeline Corporation (NYSE:PBA)
Talisman Energy Inc (NYSE:TLM) has earned a “SUS” credit rating from analysts at Morningstar. . They also gave their stock a three star rating. On Monday shares of Talisman Energy Inc. (NYSE:TLM) closed at $7.71. Company’s sales growth for last 5 years was -9.10% and EPS growth for next 5 years is recorded as 5.70%.…
-
5 Active Stocks: Apollo Global Management, LLC (NYSE:APO), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), INSYS Therapeutics (NASDAQ:INSY), BlackBerry Ltd (NASDAQ:BBRY), Boyd Gaming (NYSE:BYD)
Apollo Global Management LLC (NYSE:APO) has teamed up with Rickmers Group of Hamburg, which was founded 180 years ago, to invest as much as $500 million in container vessels. Since its inception in 2013, the joint venture acquired 12 ships on the second-hand market, according to Rickmers. On last trading day Apollo Global Management, LLC…
-
Stocks Gaining Momentum: Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Cohu (NASDAQ:COHU), The Walt Disney Company (NYSE:DIS), Ford Motor Company (NYSE:F), General Electric (NYSE:GE)
Cantor Fitzgerald reissued their buy rating on shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) in a research report sent to investors on Wednesday morning. The firm currently has a $37.00 price target on the stock, up from their previous price target of $30.00. On Friday shares of Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) closed at $33.68. On February…
-
Mix Sector Stocks News: International Business Machines Corporation (NYSE:IBM), NPS Pharmaceuticals (NASDAQ:NPSP), Telecom Argentina (NYSE:TEO), ARM Holdings (NASDAQ:ARMH), Eagle Pharmaceuticals (NASDAQ:EGRX)
Unless a Federal judge overturns the deal, International Business Machines Corporation (NYSE:IBM) is going to be granting amnesty to customers using Power Systems iron who have let their Software Maintenance, or SWMA in IBMspeak, lapse. This maintenance service is available for the systems software, compilers, middleware, and related core software that is used by IBM…
-
Stock in News: Groupon (NASDAQ:GRPN), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX), Actavis plc (NYSE:ACT), Cisco Systems (NASDAQ:CSCO), Independent Bank Corp. (NASDAQ:INDB)
On 12 February, Groupon, Inc. (NASDAQ:GRPN) announced Revenue increased 20%, to $925.4 million in the fourth quarter 2014, compared with $768.4 million in the fourth quarter 2013. Excluding the $32.5 million unfavorable impact from year-over-year changes in foreign exchange rates throughout the quarter, revenue increased 25% compared with fourth quarter 2013. On Wednesday shares of…